Fatih GÜZELBULUT, Mesut SEZİKLİ, Akkan Züleyha ÇETİNKAYA, Suna YAPALI, ALİ TÜZÜN İNCE, Ayşe Oya KURDAŞ

7 günlük standard üçlü tedaviye C ve E vitamini eklenmesi Helikobakter pilori eradikasyon oranını arttırır

Giriş ve Amaç: Türkiye’de Helikobakter pilori prevalansı yaklaşık %80’dir. Proton pompa inhibitörü, amoksisilin ve klaritromisinden oluşan standard üçlü tedavi rejimi ile eradikasyon oranı zamanla azalmaktadır. Eradikasyon oranını arttırmak amacı ile bu rejimlere probiyotikler ve çeşitli vitaminler eklenmiştir. Bu çalışmanın amacı 7 günlük standard üçlü tedaviye 14 gün süre ile C ve E vitamini eklenmesinin Helikobakter pilori eradikasyon oranını arttırıp arttırmayacağını araştırmaktır. Gereç ve Yöntem: Bu çalışmaya 53 Helikobakter pilori pozitif nonülser dispepsili hasta dahil edildi. Tüm hastalar 7 günlük lansoprazol 30 mg BID, amoksisilin 1000 mg BID ve klaritromisin 500 mg BID ile birlikte 14 günlük vitamin C 500 mg BID ve vitamin E 200 IU BID aldı. Eradikasyon oranları intention-to-treat ve per-protocol analizleri ile hesaplandı. Bulgular: Elli hasta çalışmayı tamamladı. Helikobakter pilori eradikasyonu intention-to-treat analizde 53 hastanın 31’inde (58,5%), per-protocol analizde 50 hastanın 31’inde(62%) sağlandı. Sonuç: Bu çalışmada elde edilen eradikasyon oranı başarılı olarak kabul edilen %80’in altında olsa da daha önceki çalışmalarda 7 günlük standard üçlü tedavi ile elde edilen oranlardan daha yüksektir. Tedaviye antioksidan C ve E vitaminlerinin eklenmesi eradikasyon oranını arttırmaktadır.

Anahtar Kelimeler:

Vitamin C, vitamin E, Helikobakter pilori eradikasyonu

Supplementation of 7-day standard triple therapy with vitamins C and E increases the Helicobacter pylori eradication rate

Background and Aims: In Turkey, the estimated prevalence of Helicobacter pylori infection is approximately 80%. The eradication rate has been decreasing over time with standard triple therapy regimens including a proton pump inhibitor plus amoxicillin plus clarithromycin. These regimens have been supplemented with probiotics and various antioxidants to increase the eradication rate. The aim of this study was to evaluate whether supplementation of the 7-day standard triple therapy with vitamins C and E for 14 days would increase the Helicobacter pylori eradication rate. Materials and Methods: This study included 53 patients with Helicobacter pylori-positive non-ulcer dyspepsia. All patients received lansoprazole 30 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID for 7 days, as well as vitamin C 500 mg BID and vitamin E 200 IU BID for 14 days. Eradication rates were calculated using both intention-to-treat and per-protocol analyses. Results: Fiftythree patients were analyzed using intention-to-treat analysis. Fifty patients completed the study. Helicobacter pylori eradication was achieved in 31 (58.5%) of the 53 patients included in the intention-to-treat analysis and in 31 (62%) of the 50 patients included in the per-protocol analysis. Conclusions: Although this eradication rate is lower than the accepted 80% eradication rate, it is higher than eradication rates achieved in previous studies with 7-day standard triple therapy. Supplementation with antioxidants increases the eradication rate.

Keywords:

Vitamin C, vitamin E, Helicobacter pylori eradication,

PDF

___

Marshall BJ. The 1995 Albert Lasker Medical Research Award. He- licobacter pylori. The etiologic agent for peptic ulcer. JAMA 1995; 274: 1064-6.
Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infec- tion and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-73.
Wilkinson M. Helicobacter pylori: an overview. Br J Biomed Sci 2001; 58: 59-60.
Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylo- ri infection with gastric carcinoma: a meta-analysis. Am J Gastro- enterol 1999; 94: 2373-9.
Akın L, Tezcan S, Hasçelik G, Çakır B. Seroprevalence and some correlates of Helicobacter pylori at adult ages in Gülveren Health District, Ankara, Turkey. Epidemiol Infect 2004; 132: 847-56.
Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III C onsensus Report. Gut 2007; 56: 772-81.
Sezikli M, Cetinkaya ZA, Sezikli H, et al. Oxidative stress in Helico- bacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? Helicobacter 2009; 14: 280-5.
Sjunnesson H, Sturegård E, Willén R, Wadström T. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp Med 2001; 51: 418- 23.
Sun YQ, Girgensone I, Leanderson P, et al. Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2005; 10: 33-42.
Zhang ZW, Patchett SE, Perrett D, et al. The relation between gas- tric vitamin C concentrations, mucosal histology, and CagA sero- positivity in the human stomach. Gut 1998; 43: 322-6.
Kadayıfçı A, Şimşek H, Tatar G. The efficiency of-omeprazole and dual antibiotic treatment schemes for H.pylori eradication. Turk J Gastroenterol 1996; 7: 228-32.
Uygun A, Ares Y, Erdil A, et al. Efficacy of omeprazole plus two an- timicrobials for the eradication of Helicobacter pylori in a Turkish population. Clin Ther 1999; 21: 1539-48.
Uygun A, Tüzün A, Yeşilova Z, et al. Helicobacter pylori eradikas- yon tedavisinde 7 ve 14 günlük lansoprazol, amoksisilin, klaritromi- sin protokolünün karşılaştırılması. Akademik Gastroenteroloji Der- gisi 2005; 4: 172-5.
Gümürdülü Y, Serin E, Özer B, et al. Low eradication rate of Heli- cobacter pylori with triple 7-14 days and quadriple therapy in Tur- key. World J Gastroenterol 2004; 10: 668-71.
Güliter S, Keleş H, Özkurt ZN, et al. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of Helicobacter pylori? Turk J Gastroenterol 2005; 16: 29-33.
Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; 1: 1396-7.
Halliwell B, Gutteridge JM eds. Free Radicals in Biology and Medi- cine, 3rd ed. Oxford, UK: Oxford Science Publications, 2000.